Archive for November, 2011

New Study Finds Platelet Rich Plasma (PRP) May Combat Degenerative Disease of the Intervertebral Discs of the Spine

Monday, November 28th, 2011 by Beny Charchian, M.D., M.S.

 

Our spines consist of intervertebral discs which lie in-between the vertebrae, acting like gelatinous “shock-absorbers”.  As we age, the annulus fibrosus, which is the strong outer ring of these discs, weakens and defects in the ring can cause a disc herniation, leading to low back pain and lower extremity pain.

A new study shows promise in combating these degenerative changes with the use of Platelet-Rich Plasma, more commonly known as PRP.  PRP is a useful delivery system of our body’s own growth factors, enhancing extracellular matrix production and cell proliferation to rejuvenate the tissue in the annulus fibrosis.111 New Study Finds Platelet Rich Plasma (PRP) May Combat Degenerative Disease of the Intervertebral Discs of the Spine

The use of regenerative medicine techniques in the spine may provide new hope for the treatment of chronic neck and back pain which adversely affects the quality of life for millions of Americans.  At The Orthohealing Center, we have been performing Spine PRP injections  for years with promising results.

avatar

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

“Rheumatology” Journal Evaluates PRP Platelet-Rich Plasma Injections for Hip Osteoarthritis

Monday, November 21st, 2011 by Beny Charchian, M.D., M.S.

40 patients affected by severe hip osteoarthritis were included in the study which was designed to assess the safety and symptomatic changes of PRP injections for hip arthritis. Each patient received three intra-articular injections of PRP, which were administered once a week.

Statistically significant reductions in pain scores were reported at 7 weeks and 6 months.  23 (57.5%) patients reported a clinically relevant reduction of pain (average of 45%, range 30–71%). More importantly, pain relief was shown to be sustained at 6 months with a parallel reduction of disability. Side effects were negligible and were limited to a sensation of heaviness in the injection site.

We look forward to more studies being published detailing the safety and efficacy of Platelet-Rich Plasma Injections for a wide array for joint, tendon, and ligament problems which have failed to respond to other hip OA1 300x225  “Rheumatology” Journal  Evaluates PRP Platelet Rich Plasma Injections for Hip Osteoarthritistreatments- setting the stage for a new era in regenerative medicine.

avatar

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.

New Study from Cedars-Sinai in Los Angeles Reveals Stem Cells Reverse Heart Damage

Friday, November 18th, 2011 by Beny Charchian, M.D., M.S.

CNN recently reported on a new story out of Cedars-Sinai and the University of Louisville’s Jewish Hospital that focused on a study by Dr. Robert Bolli where  16 patients with heart failure received stem cell therapy.  Within just one year, the heart function of the patients in the study markedly improved.  While the researchers expected a positive outcome, “We were surprised by the magnitude of improvement … we would possibly be curing heart failure. It would be a revolution …” said Dr. Bolli who leads a group of researchers at the University of Louisville .   Perhaps even more important, no treated patient in either study suffered a significant health setback.

As is evidenced by this new study and many more like it in recent years, regenerative medicine holds tremendous promise not only for cardiology but for numerous realms in healthcare including orthopedics & sports medicine.  The Orthohealing Center and The Orthobiologic Institute continue to research the applications of regenerative medicine in non-surgical orthopedic care and hopes to see similar postive outcomes as those seen in this study in joints and in the spine.

While incredibly promising, larger trials are still needed to determine if these thheart2 300x168 New Study from Cedars Sinai in Los Angeles Reveals Stem Cells Reverse Heart Damageerapies are safe  and effective.   Dr. Bolli said he would have to temper his enthusiasm until he can duplicate the results in larger studies, definitive enough to get stem cell therapy approved as a standard treatment.  But, for many patients who have failed conservative and traditional treatments, regenerative medicine with stem cells and growth factors sheds new light on an otherwise dim outlook on the road to recovery…

avatar

Beny Charchian, M.D., M.S.

Dr. Charchian specializes in Interventional Pain Management integrating Fluoroscopy (live X-Ray), in addition to treating an array of spine and joint disorders non-surgically. He has extensive training in electrodiagnostic studies to evaluate nerve injuries. He completed a Pain Medicine Fellowship at UCLA and is currently a Clinical Instructor of Medicine at The David Geffen School of Medicine at UCLA as well as a Clinical Assistant Professor of Physical Medicine & Rehabilitation, Western University of Health Sciences.